VEA
VMD icon

Virtus ETF Advisers’s Viemed Healthcare VMD Stock Holding History

Virtus ETF Advisers’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,939
Closed -$89.4K – 525
2025
Q2 		$89.4K Buy
+12,939
New +$87.8K 0.05% 317

Other funds holding VMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $201M AUM 9.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KLP
Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Virtus ETF Advisers's VMD Position: Q3 2025 in Review

Virtus ETF Advisers sold out of Viemed Healthcare (VMD) in Q3 2025, closing a stake of 12,939 shares — an estimated $89.4K sold.

Virtus ETF Advisers first reported a position in VMD in Q2 2025 and held it in 1 quarter. The position peaked at $89.4K in Q2 2025. 131 funds tracked by Wall St. Rank hold VMD as of Q3 2025.

  • Virtus ETF Advisers reported no remaining Viemed Healthcare position as of Q3 2025 after selling out during the quarter.
  • Virtus ETF Advisers sold 12,939 Viemed Healthcare shares in Q3 2025, an estimated $89.4K.
  • Virtus ETF Advisers first reported a position in Viemed Healthcare in Q2 2025 and held it in 1 quarter.
  • Virtus ETF Advisers's Viemed Healthcare position peaked at $89.4K in Q2 2025.
  • 131 funds tracked by Wall St. Rank held Viemed Healthcare as of Q3 2025.

Based on Virtus ETF Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.